New
HealthMore in Health→
Injectable Semaglutide Shows Early Promise for Improving Fertility in Women with PMOS
A proof-of-concept study from CU Anschutz suggests injectable semaglutide may improve both reproductive and metabolic outcomes in women with polyendocrine metabolic ovarian syndrome (PMOS).
Key Takeaways
- Injectable semaglutide shows early promise for improving fertility in women with PMOS.
- Study published in Fertility and Sterility from CU Anschutz.
DE
DT Editorial Team··via medicalxpress.com